ANVISA Approves Regulatory Impact Analysis on Medical Cannabis
The Brazilian Health Regulatory Agency (ANVISA) recently approved a Regulatory Impact Analysis (RIA) report on medical cannabis. This development marks an important step towards the potential reshaping of cannabis regulations in Brazil, promising wide-ranging implications for public health, medical research, Read More …